Regulation_NN
of_IN
Fas_NN
ligand_NN
expression_NN
and_CC
cell_NN
death_NN
by_IN
apoptosis-linked_JJ
gene_NN
4_CD
._.

Programmed_VBN
cell_NN
death_NN
is_VBZ
a_DT
process_NN
required_VBN
for_IN
the_DT
normal_JJ
development_NN
of_IN
an_DT
organism_NN
._.

One_CD
of_IN
the_DT
best_JJS
understood_VBN
apoptotic_JJ
pathways_NNS
occurs_VBZ
in_IN
T_NN
lymphocytes_NNS
and_CC
is_VBZ
mediated_VBN
by_IN
Fas\/Fas_NN
ligand_NN
-LRB-_-LRB-
FasL_NN
-RRB-_-RRB-
interaction_NN
._.

During_IN
studies_NNS
of_IN
apoptosis_NN
induced_VBN
by_IN
T_NN
cell-receptor_NN
engagement_NN
,_,
we_PRP
identified_VBD
ALG-4F_NN
,_,
a_DT
truncated_VBN
transcript_NN
that_WDT
prevents_VBZ
T_NN
cell-receptor-induced_JJ
FasL_NN
upregulation_NN
and_CC
cell_NN
death_NN
._.

Overexpression_NN
of_IN
full-length_JJ
ALG-4_NN
induced_VBD
transcription_NN
of_IN
FasL_NN
and_CC
,_,
consequently_RB
,_,
apoptosis_NN
._.

These_DT
results_NNS
indicate_VBP
that_IN
ALG-4_NN
is_VBZ
necessary_JJ
and_CC
sufficient_JJ
for_IN
FasL_NN
expression_NN
._.

Fas\/FasL_NN
interaction_NN
initiates_VBZ
cell_NN
death_NN
in_IN
many_JJ
other_JJ
systems_NNS
,_,
and_CC
its_PRP$
dysregulation_NN
is_VBZ
a_DT
mechanism_NN
by_IN
which_WDT
several_JJ
pathologic_JJ
conditions_NNS
arise_VBP
._.

Understanding_VBG
the_DT
molecular_JJ
mechanisms_NNS
of_IN
FasL_NN
regulation_NN
could_MD
be_VB
very_RB
useful_JJ
in_IN
elucidating_VBG
how_WRB
these_DT
diseases_NNS
develop_VBP
and_CC
in_IN
identifying_VBG
potential_JJ
therapeutic_JJ
targets_NNS
._.

